Literature DB >> 8097618

Should protracted withdrawal from drugs be included in DSM-IV?

S L Satel1, T R Kosten, M A Schuckit, M W Fischman.   

Abstract

OBJECTIVE: The authors reviewed both clinical data and selected laboratory research related to withdrawal from alcohol, opiates, and stimulants in order to draw a conclusion about whether the phenomenon of protracted withdrawal exists and should be included in DSM-IV.
METHOD: Studies were located through computerized searches and reference sections of published articles.
RESULTS: Symptoms extending beyond the period of acute withdrawal in alcohol and opiate dependence have been fairly consistently described; this is not the case with cocaine. Nevertheless, protracted alcohol and opiate withdrawal has not been conclusively demonstrated because of the failure of studies to do multiple time point sampling, to use standardized instruments and control groups, and to re-administer the substance in an attempt to suppress withdrawal symptoms. Further, the concept of protracted withdrawal itself is ambiguously defined. This confounds interpretation of the literature and precludes derivation of a unified concept of the term, which would be necessary for adding the diagnosis to DSM-IV.
CONCLUSIONS: There is insufficient documentation to justify inclusion of protracted withdrawal in DSM-IV because of methodologic limitations of the studies and lack of consensus definition of the term itself. An outline for conceptualizing protracted withdrawal is offered in which the symptoms can be seen as: 1) a global post-use syndrome, 2) attenuated physiologic rebound, 3) toxic residuals, 4) expression of preexisting symptoms unmasked by cessation of use. Future efforts to identify signs and symptoms of protracted withdrawal should carefully define the parameters of the syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097618     DOI: 10.1176/ajp.150.5.695

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  25 in total

1.  Evidence-based addiction medicine: the use of lofexidine for opioid detoxification.

Authors:  Babatunde Adetunji; Maju Mathews; Adedapo Williams; Olusanya Rufai
Journal:  Psychiatry (Edgmont)       Date:  2004-11

2.  Protracted manifestations of acute dependence after a single morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

Review 3.  Motivational Processes Underlying Substance Abuse Disorder.

Authors:  Paul J Meyer; Christopher P King; Carrie R Ferrario
Journal:  Curr Top Behav Neurosci       Date:  2016

4.  Craving among long-abstinent smokers: an Internet survey.

Authors:  John R Hughes
Journal:  Nicotine Tob Res       Date:  2010-02-17       Impact factor: 4.244

Review 5.  Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.

Authors:  Linda Gowing; Robert Ali; Jason M White
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

6.  Serum cortisol secretion during heroin abstinence is elevated only nocturnally.

Authors:  Su-xia Li; Jing Li; David H Epstein; Xiang Yang Zhang; Thomas R Kosten; Lin Lu
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

7.  Personality measures in former heroin users receiving methadone or in protracted abstinence from opiates.

Authors:  L J Cohen; E Gertmenian-King; L Kunik; C Weaver; E D London; I Galynker
Journal:  Acta Psychiatr Scand       Date:  2005-08       Impact factor: 6.392

Review 8.  [The importance of sleep for healthy alcohol consumers and alcohol dependent patients].

Authors:  H Gann; D van Calker; B Feige; D Riemann
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

Review 9.  Alcohol's effects on sleep in alcoholics.

Authors:  K J Brower
Journal:  Alcohol Res Health       Date:  2001

10.  Increased habenular connectivity in opioid users is associated with an α5 subunit nicotinic receptor genetic variant.

Authors:  Kaylah Curtis; Humsini Viswanath; Kenia M Velasquez; David L Molfese; Mark J Harding; Eduardo Aramayo; Philip R Baldwin; Elisa Ambrosi; Alok Madan; Michelle Patriquin; B Christopher Frueh; J Christopher Fowler; Thomas R Kosten; David A Nielsen; Ramiro Salas
Journal:  Am J Addict       Date:  2017-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.